September 11, 2024
This is the second in a three-part series from Medscape Medical News on the impact of artificial intelligence (AI) on drug discovery and development. Part 1 […]
September 11, 2024
This is the first in a three-part series from Medscape Medical News on the impact of artificial intelligence (AI) on drug discovery and development. Part 2 […]
August 19, 2024
Health Canada is proceeding with plans to add more flexibility to processes for approving medical treatments through an approach known as “agile licensing.” The plans have […]
August 14, 2024
Rising consolidation among pharmacy benefit managers (PBMs) allows the companies to profit at the expense of patients and independent pharmacists. That’s the conclusion of a recent […]
May 2, 2024
LONDON – The Royal College of Physicians Annual Conference in London held a debate that asked: should doctors engage more with the pharmaceutical industry? On one […]
April 26, 2024
At an April 25 meeting, the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization for two biosimilar medicines: Tofidence, […]
March 22, 2024
A marketing authorization should be given for orphan medicine Agilus (dantrolene sodium, hemiheptahydrate) for the treatment of malignant hyperthermia, the European Medicines Agency (EMA) has said. […]